About Us
Company Introduction
Strategic Development
Social Responsibility
Scientific Research
Innovative Layout
Innovative Field
International
Global Expansion
Cooperative Partner
Global R&D Centers
International Cooperation
Investor Relations
Information Disclosure
Corporate Governance
Stock Information
ESG
Contact us
Products Services
Product center
Product branding
Quality & Safety
News
Company News
Media Coverage
Media Inquiries
Multimedia zone
Career
Talent
R&D Team
Employee Life
Job Opportunities
EN
CN
About Us
· Company Introduction
· Strategic Development
· Social Responsibility
Scientific Research
· Innovative Layout
· Innovative Field
Products Services
· Product center
· Product branding
· Quality & Safety
News
· Company News
· Media Coverage
· Media Inquiries
· Multimedia zone
Vocational
· Concept about Talent
· R&D Team
· Employee Life
· Job Opportunities
>
News
>
Company
Return
2024 Grand Pharma Annual Report
2025-05-06
Prev
Next
Related news
The NDA of Grand Pharma’s Global Innovative RDC TLX591-CDx Is Accepted by the NMPA
2026-01-19
Grand Pharma 2025 Annual Highlights Review
2026-01-26
Grand Pharma’s Subsidiary Has Entered Into a Share Purchase Agreement to Acquire All Equity of Hebei Yuanda Jiufu Biotechnology Co., Ltd. and Baoding Jiahe Fine Chemical Co., Ltd.
2026-01-04
